Article
Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan.
Gynecologic oncology - 1 Feb 2006
Amikura Takayuki, Sekine Masayuki, Hirai Yasuo, Fujimoto Seiichiro, Hatae Masayuki, Kobayashi Iwao, Fujii Tsuneo, Nagata Ichiro, Ushijima Kimio, Obata Koshiro, Suzuki Mitsuaki, Yoshinaga Mitsuhiro, Umesaki Naohiko, Satoh Shinji, Enomoto Takayuki, Motoyama Satoru, Nishino Koji, Haino Kazufumi, Tanaka Kenichi
Abstract excerpt
OBJECTIVE: To investigate whether somatic mutations in cell cycle checkpoint genes, TP53 and p21, are involved in the development of ovarian cancer with or without BRCA1 germline mutation. METHODS: We analyzed somatic genetic alterations of TP53 and p21 in 46 ovarian cancer patients with BRCA1 germline mutations and 93 sporadic patients, using direct sequencing for the entire coding sequences in TP53 and p21....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
